American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

BioStem Technologies, Inc. (BSEM)

$4.01 +4.59% OTC: BSEM · 15-min delayed

POMPANO BEACH, Florida
Public · OTC: BSEM

BSEMOTC

About BioStem Technologies, Inc.

BIOSTEM TECHNOLOGIES NEW

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: BSEM
Headquarters: POMPANO BEACH, Florida
Industry: Pharmaceuticals

Registry IDs

Ticker: BSEM OTC
SEC CIK: 1658678
EIN: 270400416
SIC: 2836 Biological Products, (No Diagnostic Substances)

Embed this company’s badge

Show BioStem Technologies, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/biostem-technologies-inc/"><img src="https://americancompanies.com/badge/biostem-technologies-inc.svg" alt="BioStem Technologies, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow BioStem Technologies, Inc. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

OTC: BSEM

$4.01 +4.59%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.22 $13.74

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

BioStem Technologies, Inc. (BSEM) Stock Price

Trading 71% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review BioStem Technologies, Inc..

Write a review

Newsroom

News about BioStem Technologies, Inc.

BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference GlobeNewswire Inc. · 2026-02-20 · positive BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings' Surgical and Wound Care Business Benzinga · 2026-01-21 · positive BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference GlobeNewswire Inc. · 2025-12-10 · positive BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers GlobeNewswire Inc. · 2025-10-31 · positive BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program GlobeNewswire Inc. · 2025-10-02 · positive North America Diabetic Foot Ulcer Treatment Market Rises at 5.74% CAGR by 2034 GlobeNewswire Inc. · 2025-09-15 · positive

News & sentiment via Polygon.io

FAQ

BioStem Technologies, Inc.: frequently asked questions

Is BioStem Technologies, Inc. an American company?

BioStem Technologies, Inc. is a US-based company headquartered in Pompano Beach, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is BioStem Technologies, Inc. headquartered?

BioStem Technologies, Inc. is headquartered in Pompano Beach, Florida, United States.

Is BioStem Technologies, Inc. publicly traded?

Yes — BioStem Technologies, Inc. is a publicly traded company. Its stock trades under the ticker symbol BSEM on the OTC.

What does BioStem Technologies, Inc. do?

BioStem Technologies, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore